Compile Data Set for Download or QSAR
maximum 50k data
Report error Found 360 Enz. Inhib. hit(s) with all data for entry = 7330
TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189800(US10213433, Compound 374 | US11369599, Compound 37...)
Affinity DataKi: <0.00100nM ΔG°: <-68.5kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189797(US11369599, Compound 376 | US9174982, 371 | US9174...)
Affinity DataKi: <0.00100nM ΔG°: <-68.5kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189799(US10213433, Compound 373 | US11369599, Compound 37...)
Affinity DataKi: <0.00100nM ΔG°: <-68.5kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189804(US10213433, Compound 378 | US11369599, Compound 37...)
Affinity DataKi: <0.00100nM ΔG°: <-68.5kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189797(US11369599, Compound 376 | US9174982, 371 | US9174...)
Affinity DataKi: <0.00100nM ΔG°: <-68.5kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189803(US11369599, Compound 377 | US9174982, 377)
Affinity DataKi: <0.00100nM ΔG°: <-68.5kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189567(US10213433, Compound 129 | US11369599, Compound 12...)
Affinity DataKi:  0.00200nM ΔG°:  -66.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189456(US10213433, Compound 2 | US11369599, Compound 2 | ...)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189458(US10213433, Compound 4 | US11369599, Compound 4 | ...)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM60828(ABT-199 | BDBM189459 | US10213433, Compound 5 | US...)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189463(US9174982, 39 | US9174982, 9)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189464(US10213433, Compound 10 | US11369599, Compound 10 ...)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189466(US10213433, Compound 12 | US11369599, Compound 12 ...)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189467(US10213433, Compound 13 | US11369599, Compound 13 ...)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189469(US10213433, Compound 15 | US11369599, Compound 15 ...)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189472(US10213433, Compound 24 | US11369599, Compound 24 ...)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189473(US10213433, Compound 25 | US11369599, Compound 25 ...)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189476(US10213433, Compound 28 | US11369599, Compound 28 ...)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189477(US9174982, 29 | US9174982, 34)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189478(US10213433, Compound 30 | US11369599, Compound 30 ...)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189479(US10213433, Compound 31 | US11369599, Compound 31 ...)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189480(US10213433, Compound 32 | US11369599, Compound 32 ...)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189481(US9174982, 33 | US9174982, 63)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189477(US9174982, 29 | US9174982, 34)
Affinity DataKi:  0.0100nM ΔG°:  -62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189483(US10213433, Compound 35 | US11369599, Compound 35 ...)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189485(US10213433, Compound 37 | US11369599, Compound 37 ...)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189488(US10213433, Compound 40 | US11369599, Compound 40 ...)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189489(US10213433, Compound 41 | US11369599, Compound 41 ...)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189492(US9174982, 44)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189493(US10213433, Compound 45 | US11369599, Compound 45 ...)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189495(US10213433, Compound 47 | US11369599, Compound 47 ...)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189496(US10213433, Compound 48 | US11369599, Compound 48 ...)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189499(US10213433, Compound 51 | US11369599, Compound 51 ...)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189501(US10213433, Compound 53 | US11369599, Compound 53 ...)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189503(US10213433, Compound 55 | US11369599, Compound 55 ...)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189506(US10213433, Compound 58 | US11369599, Compound 58 ...)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189508(US9174982, 60)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189510(US10213433, Compound 62 | US11369599, Compound 62 ...)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189481(US9174982, 33 | US9174982, 63)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189512(US9174982, 64)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189513(US10213433, Compound 65 | US11369599, Compound 65 ...)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189514(US10213433, Compound 66 | US11369599, Compound 66 ...)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189515(US10213433, Compound 67 | US11369599, Compound 67 ...)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189519(US9174982, 71)
Affinity DataKi:  0.0100nM ΔG°:  -62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189520(US9174982, 72)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189521(US10213433, Compound 73 | US11369599, Compound 73 ...)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189523(US10213433, Compound 75 | US11369599, Compound 75 ...)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189526(US10213433, Compound 78 | US11369599, Compound 78 ...)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189527(US10213433, Compound 79 | US11369599, Compound 79 ...)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetApoptosis regulator Bcl-2(Human)
Abbvie

US Patent
LigandPNGBDBM189528(US10213433, Compound 80 | US11369599, Compound 80 ...)
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 25°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
In DepthDetails US Patent


Displayed 1 to 50 (of 360 total ) | Next | Last >>
Jump to: